Details for 2018708210

Up to date per 14.05.2026

Actions

Title / Product Name

DOSIERUNGSSCHEMA EINES WNT-INHIBITORS UND EINES ANTI-PD-1-ANTIKÖRPERMOLEKÜLS IN KOMBINATION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018708210

EP Publication Number

3582811

E-Number

1701470

Language

PCT Number

IB18050846

Publication Date

25.12.2019 A

10.07.2024 B1

Registration Date

10.07.2024

AT Publication Date

15.07.2024

Application Date

12.02.2018

Registration Number

Priorities

14.02.2017

201762458640 P

12.01.2018

201862616682 P

IPC

A61K 39/395 20060101AFI20180824BHEP

Maximum Duration of Protection

12.02.2038

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

DOBSON, Jason Russellc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

MOODY, Susanc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

MCLAUGHLIN, Margaret Elisec/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US